These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

499 related items for PubMed ID: 15788594

  • 1. Value of FDG PET in the assessment of patients with multiple myeloma.
    Bredella MA, Steinbach L, Caputo G, Segall G, Hawkins R.
    AJR Am J Roentgenol; 2005 Apr; 184(4):1199-204. PubMed ID: 15788594
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Comparative study of fluorodeoxyglucose positron emission tomography and magnetic resonance imaging for the detection of spinal bone marrow infiltration in untreated patients with multiple myeloma.
    Hur J, Yoon CS, Ryu YH, Yun MJ, Suh JS.
    Acta Radiol; 2008 May; 49(4):427-35. PubMed ID: 18415787
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. F-18 FDG uptake of bone marrow on PET/CT scan: it's correlation with CD38/CD138 expressing myeloma cells in bone marrow of patients with multiple myeloma.
    Ak I, Gulbas Z.
    Ann Hematol; 2011 Jan; 90(1):81-7. PubMed ID: 20690019
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. ¹⁸F-FDG PET/CT: a review of diagnostic and prognostic features in multiple myeloma and related disorders.
    Dammacco F, Rubini G, Ferrari C, Vacca A, Racanelli V.
    Clin Exp Med; 2015 Feb; 15(1):1-18. PubMed ID: 25218739
    [Abstract] [Full Text] [Related]

  • 8. 11C-choline vs. 18F-FDG PET/CT in assessing bone involvement in patients with multiple myeloma.
    Nanni C, Zamagni E, Cavo M, Rubello D, Tacchetti P, Pettinato C, Farsad M, Castellucci P, Ambrosini V, Montini GC, Al-Nahhas A, Franchi R, Fanti S.
    World J Surg Oncol; 2007 Jun 20; 5():68. PubMed ID: 17584499
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [The value of fluorodeoxyglucose positron emission tomography in multiple myeloma].
    Adam Z, Bolcák K, Stanícek J, Pour L, Hájek R, Krejcí M, Prásek J, Neubauer J, Mareschova Y, Vorlícek J.
    Vnitr Lek; 2006 Mar 20; 52(3):207-14. PubMed ID: 16722151
    [Abstract] [Full Text] [Related]

  • 12. (18)F-FDG dynamic PET/CT in patients with multiple myeloma: patterns of tracer uptake and correlation with bone marrow plasma cell infiltration rate.
    Sachpekidis C, Mai EK, Goldschmidt H, Hillengass J, Hose D, Pan L, Haberkorn U, Dimitrakopoulou-Strauss A.
    Clin Nucl Med; 2015 Jun 20; 40(6):e300-7. PubMed ID: 25783508
    [Abstract] [Full Text] [Related]

  • 13. Whole-body (18)F-FDG PET identifies high-risk myeloma.
    Durie BG, Waxman AD, D'Agnolo A, Williams CM.
    J Nucl Med; 2002 Nov 20; 43(11):1457-63. PubMed ID: 12411548
    [Abstract] [Full Text] [Related]

  • 14. Role of 18F-FDG PET/CT in the assessment of bone involvement in newly diagnosed multiple myeloma: preliminary results.
    Nanni C, Zamagni E, Farsad M, Castellucci P, Tosi P, Cangini D, Salizzoni E, Canini R, Cavo M, Fanti S.
    Eur J Nucl Med Mol Imaging; 2006 May 20; 33(5):525-31. PubMed ID: 16453155
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The value of FDG PET/CT in the initial staging and bone marrow involvement of patients with multiple myeloma.
    Sager S, Ergül N, Ciftci H, Cetin G, Güner SI, Cermik TF.
    Skeletal Radiol; 2011 Jul 20; 40(7):843-7. PubMed ID: 21229354
    [Abstract] [Full Text] [Related]

  • 18. A prospective comparison of 18F-fluorodeoxyglucose positron emission tomography-computed tomography, magnetic resonance imaging and whole-body planar radiographs in the assessment of bone disease in newly diagnosed multiple myeloma.
    Zamagni E, Nanni C, Patriarca F, Englaro E, Castellucci P, Geatti O, Tosi P, Tacchetti P, Cangini D, Perrone G, Ceccolini M, Brioli A, Buttignol S, Fanin R, Salizzoni E, Baccarani M, Fanti S, Cavo M.
    Haematologica; 2007 Jan 20; 92(1):50-5. PubMed ID: 17229635
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Whole-Body MRI versus PET in assessment of multiple myeloma disease activity.
    Shortt CP, Gleeson TG, Breen KA, McHugh J, O'Connell MJ, O'Gorman PJ, Eustace SJ.
    AJR Am J Roentgenol; 2009 Apr 20; 192(4):980-6. PubMed ID: 19304704
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.